News NICE backs digital technologies for COPD rehab More patients in England with chronic obstructive pulmonary disease (COPD) could soon be able to access rehabilitation programmes, after cost-effectiveness watchdog NICE b
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.